23.99↑0.00 (0.00%)
12:00 AM,22nd Sep 2023BSE : 542678
NSE :
Sector : Health care
ISIN Code : INE05BN01019
Last Updated: Sep 22 2023 | 12:00 AM IST
Market Cap (₹ Cr) | 0 |
Turnover (₹ Cr) | 0.00 |
Volume (Shares) | |
Face Value | 10 |
52-WK High | 0.00 |
52-WK High Date | Invalid date |
52-WK Low | 0.00 |
52-WK Low Date | Invalid date |
All Time High | 0.00 |
All Time High Date | Invalid date |
All Time Low | 0.00 |
All Time Low Date | Invalid date |
Cian Healthcare Limited was originally incorporated as a private limited company with the name of 'Cian Healthcare Private Limited' on January 07 2003. Subsequently the Company was converted into a public limited company pursuant to a special resolution passed by the shareholders dated November 19 2018 and the name of the Company was changed to 'Cian Healthcare Limited' to reflect the legal status of the Company pursuant to a fresh certificate of incorporation granted by the Registrar of Companies Pune dated November 30 2018. The Company is a WHO-GMP & ISO-9001:2015 certified transnational manufacturing Company with wide range of Pharmaceutical Nutraceutical Ayurvedic Cosmeceuticals Sexual Wellness and Food supplement products. The Company has a full-fledged F & D and regulatory department. The Company complies with the standard manufacturing practices as laid down by the World Health Organization and is also certified by the Food and Drug Control Administration The Company develops manufactures and commercializes pharmaceutical products including sales marketing quality assurance distribution compliance and regulatory aspects under 12 therapeutic segments like Orthopaedics Gynaecology Paediatrics Cardiac Diabetic Dermatology Pain Management Antibiotics Neuro Critical Care Gastro-Intestinal and Nutraceuticals alongwith 10 sales division focused on developing and growing its engagements in specialist and super specialist division. The company works under different business models like Brand Business Export Third Party Manufacturing and Government Supplies. The Company has product approvals under the license issued by Drug Controlling & Licensing Authority Uttarkhand under the license no. 82/UA/2006 in Form of 25 and 82/UA/SC/P-2006 Form of 28 for manufacturing of Tablets Capsules Oral Liquids and Ointments and also for analysis of Chemical Instrumental & Microbiology. The Company manufactures innovative products comprising of Tablets Capsules Liquid Orals Ointments Creams Lotions Gels and Sachet. The Company has special licence for manufacturing veterinary products for client like SAVAvet and Venky's. Cian has developed more than 1000 formulations and 2000 brands for domestic market under 12 therapeutic segments like Orthopaedics Gynaecology Paediatrics Cardiac Diabetic Dermatology Pain Management Antibiotics Neuro Critical Care Gastro-Intestinal and Nutraceuticals. The Company is managed by a team of professionals headed by its Managing Director having experience in the field of manufacturing of Pharmaceuticals products. The manufacturing process is supported by Total Quality Management techniques (TQM) and is supervised through various quality control equipments and qualified personnel. The Products are manufactured for domestic and foreign markets. The Company entered the International market in the year 2013-14 and are on regular basis exporting its products to various countries.
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 59 |
EPS - TTM (₹) [S] | 0.42 |
P/E Ratio (X) [S] | 0.98 |
Face Value (₹) | 10 |
Latest Dividend (%) | - |
Latest Dividend Date | - |
Dividend Yield (%) | - |
Book Value Share (₹) [S] | 24.57 |
P/B Ratio (₹) [S] | 0.98 |
[*C] Consolidated [*S] Standalone |
Scheme Name ↑↓ | Amount Invested ( ₹ Cr ) ↑↓ | No Of Shares ↑↓ | Net Asset (%) ↑↓ |
---|
Date↑↓ | Broker↑↓ | Action↑↓ | Prices(Rs)↑↓ | Report |
---|---|---|---|---|
Data Not Found |
Today's Low/High | 23.99 23.99 |
Week Low/High | 23.40 26.00 |
Month Low/High | 23.40 27.00 |
Year Low/High | 15.05 41.00 |
All time Low/High | 10.25 63.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | -6.83% | % | -2.33 | -2.28% |
1 Month | -3.58% | % | 1.75 | 2.12% |
3 Month | -9.37% | % | 4.83 | 5.41% |
6 Month | -16.03% | % | 14.77 | 16.11% |
1 Year | 26.26% | % | 13.64 | 13.55% |
3 Year | 83.83% | % | 76.59 | 78.05% |
Date | Client Name | Exchange | Transaction | Quantity | Price |
---|---|---|---|---|---|
07-07-2023 | SAHI TRADING PRIVATE LIMITED | BSE | BUY | 202000 | 25.13 |
07-07-2023 | SURAJ SHRINIWAS ZANWAR | BSE | SELL | 220000 | 25.03 |
05-07-2023 | SAHI TRADING PRIVATE LIMITED | BSE | BUY | 192000 | 26.36 |
05-07-2023 | SURAJ SHRINIWAS ZANWAR | BSE | SELL | 202000 | 26.34 |
28-06-2023 | INDIACREDIT RISK MANAGEMENT LLP | BSE | SELL | 200000 | 22.71 |
22-06-2023 | SETU SECURITIES PVT. LTD. | BSE | BUY | 42000 | 29.41 |
22-06-2023 | SETU SECURITIES PVT. LTD. | BSE | SELL | 160000 | 29.44 |
21-06-2023 | MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED | BSE | BUY | 274000 | 33.16 |
21-06-2023 | MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED | BSE | SELL | 74000 | 32.69 |
21-06-2023 | PRAKASHCHANDRA RATHI | BSE | SELL | 1024000 | 33.25 |
Load More |
Name | Price(In Rs) | Chg(%) | Mkt Cap(Rs Cr) | Sales(Rs Cr) | Profit(Rs Cr) | EPS(Rs) | P/E(x) |
---|
Category | Share(%) |
---|---|
Promoter | 51.85 |
Financial Institutions Banks | 0.00 |
Foreign Institutional Investors | 0.00 |
Insurance Companies | 0.00 |
Mutual Funds Uti | 0.00 |
Other Institutional Investors | 0.00 |
Indian Public | 41.89 |
Others Non Institutional Investors | 6.26 |
Custodians | 0.00 |
Announcement Date | Purpose | From | To | Remarks |
---|---|---|---|---|
Data Not Found |
Search for Price History
Date | Open | High | Low | Close | Shares | Trades |
---|---|---|---|---|---|---|
Data Not Found |
Load more
Company Sec. & Compli. Officer : Munjaji Purbhaji Dhumal
Independent Director : Swati Maheshwari
Director : Paresh Arun Shah
Independent Director : Sunil Kumar
Registered Office: Milkat No 3339 BNo 1 Phursungi, From Southside CS NO 227/2,Pune,Maharashtra-412308 Ph: 91-020-26982792
Email:cs@cian.co